Melanoma: Staging and Follow-Up
Authors:
Open Access
- 28 July 2021
- journal article
- research article
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 11 (Suppl 1) , 2021162S
Abstract
Cancer staging is the process determining to which extent a cancer has spread and where it is located in the body. A thorough staging is of utmost importance, not only because it provides the most accurate prognostic estimation, but also because several crucial decisions, such as the treatment choice and the follow-up strategy, vary according to the tumor’s stage. The current staging system for melanoma is based on the 8th edition of TNM classification issued by the American Joint Committee on Cancer (AJCC) in 2017. It includes a clinical and a pathological staging, both consisting of 5 stages (0-IV). The stage of a melanoma is determined by several factors, among which the Breslow thickness, the pathological presence or absence of ulceration in the primary tumor, the presence and the number of tumor-involved regional lymph nodes, the presence or absence of in-transit, satellite and/or microsatellite metastases, and the presence of distant metastases. Following melanoma diagnosis, an accurate medical workup, in line with the stage and the physical examination, should be performed. A continuous patient monitoring is fundamental to detect a potential relapse or a second primarymelanoma and should be lifelong. However, there is still no universally adopted follow-up strategy program and different follow-up schemes have been suggested. Future prospective studies are needed to evaluate different follow-up protocols according to the adopted therapy, as novel recent therapies (targeted and immunotherapies) are being increasingly used.Keywords
This publication has 34 references indexed in Scilit:
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in MelanomaNew England Journal of Medicine, 2014
- Fine-Needle Aspiration Cytology for the Diagnosis of Metastatic MelanomaAmerican Journal of Clinical Pathology, 2013
- Sentinel Node Biopsy in Thin and Thick MelanomaAnnals of Surgical Oncology, 2013
- Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance StrategyPLOS ONE, 2013
- Sentinel lymph node biopsy for cutaneous melanoma: A 6 years studyIndian Journal of Plastic Surgery, 2013
- Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysisJNCI: Journal of the National Cancer Institute, 2010
- Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up GuidelinesJournal of Clinical Oncology, 2010
- Importance of Sentinel Lymph Node Biopsy in Patients With Thin MelanomaArchives of Surgery, 2008
- The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin MelanomaAnnals of Surgical Oncology, 2006
- Late Recurrence of Malignant MelanomaAnnals of Surgery, 1990